Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery
Jessica Mok, Mariam O. Adeleke, Adrian Brown, et al.
JAMA Surgery (2023) Vol. 158, Iss. 10, pp. 1003-1003
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

What is the pipeline for future medications for obesity?
Eka Melson, Uzma Ashraf, Dimitris Papamargaritis, et al.
International Journal of Obesity (2024)
Open Access | Times Cited: 103
Randomized Trial of Effect of Bariatric Surgery on Blood Pressure After 5 Years
Carlos A. Schiavon, Alexandre Biasi Cavalcanti, Juliana D. Oliveira, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 6, pp. 637-648
Closed Access | Times Cited: 26
Metabolic Bariatric Surgery Across the IFSO Chapters: Key Insights on the Baseline Patient Demographics, Procedure Types, and Mortality from the Eighth IFSO Global Registry Report
Wendy A. Brown, Ronald S. L. Liem, Salman Al‐Sabah, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1764-1777
Open Access | Times Cited: 25
Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels
Nursel Çalık Başaran, I Dotan, Dror Dicker
International Journal of Obesity (2024)
Open Access | Times Cited: 19
Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression
Frederick Berro Rivera, Grace Nooriza O. Lumbang, Danielle Rose Magno Gaid, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 6, pp. 2209-2228
Open Access | Times Cited: 13
Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review
Moath S. Alsaqaaby, Sarah Cooney, Carel W. le Roux, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 6, pp. 414-421
Closed Access | Times Cited: 13
Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study
Mohammad H. Jamal, Mohsen Alhashemi, Carol Dsouza, et al.
Obesity Surgery (2024) Vol. 34, Iss. 4, pp. 1324-1332
Closed Access | Times Cited: 12
Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis
Deep Dutta, Lakshmi Nagendra, Ameya Joshi, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1653-1664
Closed Access | Times Cited: 12
Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic Review
Alexandre Dréant, Claire Blanchard, David Jacobi
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1846-1854
Closed Access | Times Cited: 8
The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis
Joanne Kellett, Sara Soliman, Alicia Podwójniak, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis
Yuntao Nie, Yiran Zhang, Baoyin Liu, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1
Endocrinology: What You May Have Missed in 2024
Mohamed Aman, Athavi Jeevananthan, Maria Martinez-Cruz, et al.
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 1
Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery
Michail Kokkorakis, Angeliki Katsarou, Niki Katsiki, et al.
Metabolism (2023) Vol. 148, pp. 155689-155689
Open Access | Times Cited: 21
Pharmacotherapy before and after bariatric surgery
Khaled Alabduljabbar, Carel W. le Roux
Metabolism (2023) Vol. 148, pp. 155692-155692
Closed Access | Times Cited: 16
Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment
Caroline K. Kramer, Matthew Retnakaran, Luciana Verçoza Viana
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 8, pp. e1634-e1641
Closed Access | Times Cited: 7
Therapeutic Options for Recurrence of Weight and Obesity Related Complications After Metabolic and Bariatric Surgery: An IFSO Position Statement
Ashraf Haddad, Michel Suter, Jan Greve, et al.
Obesity Surgery (2024) Vol. 34, Iss. 11, pp. 3944-3962
Closed Access | Times Cited: 7
Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis
Federica Vinciguerra, Carla Di Stefano, Roberto Baratta, et al.
Obesity Surgery (2024) Vol. 34, Iss. 2, pp. 303-309
Open Access | Times Cited: 6
Chirurgie bariatrique : que retenir des travaux récents de la HAS pour la médecine bariatrique ?
Olivier Ziegler
Médecine des Maladies Métaboliques (2025)
Closed Access
Adipocentric Strategy for the Treatment of Type 2 Diabetes Mellitus
Juan José Gorgojo Martínez
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 678-678
Open Access
Nouvelles approches pharmacothérapeutiques pour la gestion de l’obésité
Camille Sollier, David Jacobi
Pratiques en nutrition (2025)
Closed Access
The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesity: a look at phase 2 and 3 pipelines
Sten Madsbad, Jens J. Holst
Expert Opinion on Investigational Drugs (2025), pp. 1-19
Open Access
Incidence of new onset arterial hypertension after metabolic bariatric surgery: an 8-year prospective follow-up with matched controls
Viiko Vahtera, Jukka Pajarinen, Mika Kivimäki, et al.
Journal of Hypertension (2025)
Closed Access
Semaglutide for weight loss: unanswered questions
Ploutarchos Tzoulis, Stephanie Baldeweg
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Bariatric Surgery in Women with Polycystic Ovary Syndrome
Suhaniya Samarasinghe, Casper Woods, Alexander D. Miras
Metabolism (2023) Vol. 151, pp. 155745-155745
Open Access | Times Cited: 10
Outcomes and Management of Re-Establishing Bariatric Patients
Pourya Medhati, Omnia S Saleh, Abdelrahman Nimeri, et al.
Journal of the American College of Surgeons (2024) Vol. 238, Iss. 6, pp. 1035-1043
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top